X0704 D LIVE 0001164994 RIB X PHARMACEUTICALS INC 300 GEORGE STREET SUITE 301 NEW HAVEN CT CONNECTICUT 06511 203-624-5606 DELAWARE None None Corporation true Mark Leuchtenberger c/o Rib-X Pharmaceuticals, Inc. 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Executive Officer Director Robert Conerly c/o Rib-X Pharmaceuticals, Inc. 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Executive Officer Director Jonathan Leff WP VIII Finance, L.P. , c/o Warburg Pinc 450 Lexington Avenue New York NY NEW YORK 10017 Director Cecilia Gonzalo WP VIII Finance, L.P. , c/o Warburg Pinc 450 Lexington Avenue New York NY NEW YORK 10017 Director Harry H. Penner, Jr. c/o Rib-X Pharmaceuticals, Inc. 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Director Jonathan Fleming c/o Oxford Biosciences Partners IV, L.P. 222 Berkeley Street, Suite 1650 Boston MA MASSACHUSETTS 02116 Director Raymond Whitaker c/o EuclidSR Partners, L.P. New York NY NEW YORK 10111 Director C. Boyd Clarke 265 Cheswold Lane Haverford PA PENNSYLVANIA 19041 Director Peter Greenleaf c/o Rib-X Pharmaceuticals, Inc. 300 George Street, Suite 301 New Haven CT CONNECTICUT 06511 Director Pharmaceuticals Decline to Disclose 06 false 2010-05-28 false true true false 0 15000000 5500000 9500000 false 16 0 0 0 true false RIB X PHARMACEUTICALS INC Robert Conerly Robert Conerly Chief Financial Officer 2010-06-10